{"nct_id":"NCT05677451","title":"24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2023-07-11","start_date_type":"ACTUAL","primary_completion_date":"2026-04-02","primary_completion_date_type":"ESTIMATED","completion_date":"2032-03-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}